Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29200867 | 0.83 | HTT (0.52) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL20555736 | 0.80 | HTT (0.53) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL1008954 | 0.80 | HTT (0.53) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL20555864 | 0.80 | HTT (0.53) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL1008523 | 0.79 | HTT (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL29955378 | 0.79 | HTT (0.52) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL2428998 | 0.79 | HTT (0.56) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL2760500 | 0.78 | HTT (0.70) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL20555764 | 0.77 | HTT (0.50) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL17627097 | 0.77 | HTT (0.53) | HTTCYP1A2CYP2C19ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2999338-B1 | KNOWN AND NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2017-07-12 | — | — | EP | disclosed |
| US-20160106102-A1 | KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-04-21 | — | — | US | disclosed |
| EP-2999338-A1 | KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | Bayer CropScience Aktiengesellschaft (DE) | 2016-03-30 | — | — | EP | disclosed |
| CN-105392365-A | Heterocyclic compounds known and new as pest control agents | BAYER CROPSCIENCE AG | 2016-03-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106102-A1 | KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS | DDT, ACHE, NISCH | HTT 708/4885CYP1A2 526/4885CYP2C19 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.